Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Personalis, Inc. United States | 1 | 413 |
|
MLH3 Gene Colorectal cancer, hereditary nonpolyposis type 7 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Hereditary Expanded Cancer Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 86 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 26 |
|
Tempus AI United States | 2 | 646 |
|
Comprehensive cancer panel (76 genes) Molecular Genetics Laboratory North York General Hospital Canada | 1 | 74 |
|
Molecular Genetics Laboratory North York General Hospital Canada | 10 | 18 |
|
Hereditary breast, ovarian, prostate, GI cancer panel (36 genes) Molecular Genetics Laboratory North York General Hospital Canada | 18 | 36 |
|
Hereditary GI cancer panel (31 genes) Molecular Genetics Laboratory North York General Hospital Canada | 13 | 31 |
|
Common Hereditary Cancer Screening Panel PreventionGenetics, part of Exact Sciences United States | 94 | 55 |
|
Centogene AG - the Rare Disease Company Germany | 67 | 33 |
|
Centogene AG - the Rare Disease Company Germany | 113 | 68 |
|
Centogene AG - the Rare Disease Company Germany | 155 | 107 |
|
MLH3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
PathGroup United States | 73 | 505 |
|
Ambry Genetics United States | 79 | 80 |
|
Endometrial cancer, susceptibility to, 608089 (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Colorectal cancer, hereditary nonpolyposis, type 7, 614385; HNPCC7 (Lynch syndrome) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Colorectal cancer, somatic, 114500 (MLH3 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.